Biotech Values

[apljack]

SPPI did bounce off 9 ,on the face its looks decent @ 10's, the phase 3 failure counterbalanced with aquisition news on same day is weird,lol

I don't think weird, more like calculated.

The acquisition will be a long-term positive although the big question is whether sales of Fusilev will continue to show growth and at what level. Sales of Zevalin and Folytin combined are paltry, but with modest growth potential.

aj